We thank the European Organization for Research and Treatment of Cancer (EORTC) Headquarters, EORTC Clinical Groups, and all of the principal investigators (W. Albrecht, J. Becker, R. E. Coleman, T. Conroy, R. de Wit, A. Eggermont, S. Fossa, G. Giaccone, J. C. Horiot, F. Keuppens, C. H. Koehne, J. L. Lefebvre, F. Levi, G. O. N. Oosterhof, M. Piccart, P. Postmus, H. J. Schmoll, E. F. Smit, T. A. W. Splinter, M. J. Taphoorn, P. Therasse, J. Van Meerbeeck, and H. Van Poppel) who helped us better understand the needs of cancer patients, which will ultimately lead to better patient care. We also extend a warm thanks to Cheryl Whittaker for proofreading the article. We give very special thanks to all of the patients who participated in these trials.
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites
Article first published online: 11 OCT 2013
© 2013 American Cancer Society
Volume 120, Issue 2, pages 302–311, 15 January 2014
How to Cite
Quinten, C., Martinelli, F., Coens, C., Sprangers, M. A. G., Ringash, J., Gotay, C., Bjordal, K., Greimel, E., Reeve, B. B., Maringwa, J., Ediebah, D. E., Zikos, E., King, M. T., Osoba, D., Taphoorn, M. J., Flechtner, H., Schmucker-Von Koch, J., Weis, J., Bottomley, A. and on behalf of Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups (2014), A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer, 120: 302–311. doi: 10.1002/cncr.28382
The sponsors had no role in the design of the study; the collection, analysis, or interpretation of the data; the writing of the article; or the decision to submit the article for publication.
- Issue published online: 7 JAN 2014
- Article first published online: 11 OCT 2013
- Manuscript Accepted: 2 AUG 2013
- Manuscript Revised: 4 JUL 2013
- Manuscript Received: 27 FEB 2013